Parallel Advisors, LLC Catalent, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 796 shares of CTLT stock, worth $50,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares

796

Previous 1,631 51.2%

Holding current value

$50,530

Previous $91,000 47.25%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $46,893 - $50,901	-835 Reduced 51.2%	796 $48,000
Q2 2024 Aug 08, 2024	SELL	$53.58 - $57.02 $192,512 - $204,872	-3,593 Reduced 68.78%	1,631 $91,000
Q1 2024 May 06, 2024	BUY	$42.56 - $59.82 $7,150 - $10,049	168 Added 3.32%	5,224 $294,000
Q4 2023 Feb 09, 2024	BUY	$32.18 - $46.57 $24,070 - $34,834	748 Added 17.36%	5,056 $227,000
Q3 2023 May 20, 2024	BUY	$44.2 - $50.2 $8,663 - $9,839	196 Added 4.77%	4,308 $196,000
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $8,663 - $9,839	196 Added 4.77%	4,308 $196,000
Q2 2023 May 20, 2024	SELL	$31.86 - $67.26 $17,395 - $36,723	-546 Reduced 11.72%	4,112 $178,000
Q2 2023 Aug 04, 2023	SELL	$31.86 - $67.26 $17,395 - $36,723	-546 Reduced 11.72%	4,112 $178,000
Q1 2023 May 20, 2024	SELL	$45.44 - $74.26 $25,719 - $42,031	-566 Reduced 10.83%	4,658 $306,000
Q1 2023 Apr 25, 2023	BUY	$45.44 - $74.26 $8,815 - $14,406	194 Added 4.35%	4,658 $306,000
Q4 2022 Feb 03, 2023	BUY	$41.39 - $81.0 $26,613 - $52,083	643 Added 16.83%	4,464 $200,000
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $19,464 - $30,423	-269 Reduced 6.58%	3,821 $276,000
Q2 2022 Aug 01, 2022	BUY	$87.2 - $114.05 $17,178 - $22,467	197 Added 5.06%	4,090 $439,000
Q1 2022 Apr 28, 2022	SELL	$94.19 - $124.49 $38,994 - $51,538	-414 Reduced 9.61%	3,893 $431,000
Q4 2021 Jan 20, 2022	BUY	$119.57 - $139.07 $956 - $1,112	8 Added 0.19%	4,307 $551,000
Q3 2021 Nov 02, 2021	BUY	$109.17 - $142.35 $35,371 - $46,121	324 Added 8.15%	4,299 $572,000
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $20,569 - $23,716	205 Added 5.44%	3,975 $430,000
Q1 2021 Apr 23, 2021	BUY	$101.51 - $125.27 $5,684 - $7,015	56 Added 1.51%	3,770 $397,000
Q4 2020 Feb 02, 2021	BUY	$85.88 - $105.36 $1,116 - $1,369	13 Added 0.35%	3,714 $387,000
Q3 2020 Oct 27, 2020	BUY	$72.74 - $92.5 $290 - $370	4 Added 0.11%	3,701 $317,000
Q2 2020 Jul 16, 2020	BUY	$48.02 - $79.04 $336 - $553	7 Added 0.19%	3,697 $270,000
Q1 2020 Apr 27, 2020	BUY	$36.95 - $62.95 $1,293 - $2,203	35 Added 0.96%	3,690 $191,000
Q3 2019 Nov 01, 2019	SELL	$47.45 - $58.05 $4,507 - $5,514	-95 Reduced 2.53%	3,655 $174,000
Q2 2019 Aug 05, 2019	BUY	$39.26 - $54.21 $29,130 - $40,223	742 Added 24.67%	3,750 $203,000
Q1 2019 May 01, 2019	BUY	$29.84 - $43.92 $37,687 - $55,470	1,263 Added 72.38%	3,008 $122,000
Q3 2018 Nov 01, 2018	BUY	$40.12 - $45.55 $70,009 - $79,484	1,745 New	1,745 $79,000
Q3 2017 Nov 14, 2017	SELL	$33.75 - $41.67 $303 - $375	-9 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	9	9 $0

Others Institutions Holding CTLT

# of Institutions

509

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Catalent, Inc. Transaction History